TITLE

Endovascular Therapy May Provide No Benefit When Combined With t-PA

AUTHOR(S)
Mechcatie, Elizabeth
PUB. DATE
March 2013
SOURCE
Neurology Reviews;Mar2013, Vol. 21 Issue 3, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on a study conducted by Joseph Broderick, Chair of the Department of Neurology at the University of Cincinnati and lead investigator of the International management of Stroke (IMS) III Study. The study found that treatment of patients with acute ischemic stroke with IV tissue plasminogen activator (t-pa) alone and t-pa with endovascular therapy was not different in terms of functional and safety outcomes. The study was conducted on randomized manner among 900 patients.
ACCESSION #
86412297

 

Related Articles

  • Combination of Eptifibatide and t-PA May Be Safe to Administer for Stroke. Greb, Erik // Neurology Reviews;Mar2013, Vol. 21 Issue 3, p29 

    The article focuses on a randomized trail performed to study the treatment procedures for patients suffering from acute ischemic stroke. This study was presented at the 2013 International Stroke Conference and showed that if the patients were treated with tissue plasminogen activator (t-PA) and...

  • Minimal sufficient balance-a new strategy to balance baseline covariates and preserve randomness of treatment allocation. Zhao, Wenle; Hill, Michael D.; Palesch, Yuko // Statistical Methods in Medical Research;Dec2015, Vol. 24 Issue 6, p989 

    In many clinical trials, baseline covariates could affect the primary outcome. Commonly used strategies to balance baseline covariates include stratified constrained randomization and minimization. Stratification is limited to few categorical covariates. Minimization lacks the randomness of...

  • Endovascular Stroke Treatments and IV t-PA May Have Similar Outcomes. Zoler, Mitchel L. // Neurology Reviews;Mar2013, Vol. 21 Issue 3, p28 

    The article focuses on a randomized trail performed to study treatment procedures for patients suffering from acute ischemic stroke. This study was presented at the 2013 International Stroke Conference and showed that the effect of endovascular therapy had no effect in treatment of intracranial...

  • Acute Ischemic Stroke and Timing of Treatment. Radecki, Ryan P. // JAMA: Journal of the American Medical Association;11/6/2013, Vol. 310 Issue 17, p1855 

    A letter to the editor is presented in response to an article about the association of time to tissue-type plasminogen activator (tPA) treatment and outcomes of stroke.

  • Acute Ischemic Stroke and Timing of Treatment. Saver, Jeffrey L.; Fonarow, Gregg C.; Schwamm, Lee H. // JAMA: Journal of the American Medical Association;11/6/2013, Vol. 310 Issue 17, p1856 

    A response to a letter to the editor about an article on the association of time to tissue-type plasminogen activator (tPA) treatment and outcomes of stroke is presented.

  • Alteplase for ischaemic stroke: concerns raised in UK.  // Reactions Weekly;Sep2014, Vol. 1518 Issue 1, p4 

    The article focuses on the evidence about the use of alteplase, a tissue plasminogen activator (t-PA), for the treatment of acute ischaemic stroke.

  • Heart Sounds. Martin, Lee // River Teeth;Fall2014, Vol. 16 Issue 1, p31 

    A personal narrative is presented which explores the author's experience of having the first symptoms of a stroke caused by a patent foramen ovale (PFO) and how he recovers through tissue plasminogen activator (tPA).

  • Intra-arterial Therapy for Acute Stroke: Trials and Tribulations. Jayaraman, Mahesh V.; Haas, Richard A.; Ahn, Sun H. // Medicine & Health Rhode Island;Dec2011, Vol. 94 Issue 12, p357 

    The article examines the treatment of acute ischemic stroke with intra-arterial therapy (IAT). A brief history on the significance of thombolysis and thombectomy in the management of stroke is offered. The NINDS IV trial is highlighted which evaluates the effectivness of a tissue plasminogen...

  • Managing and Treating Pediatric Stroke. Greb, Erik // Neurology Reviews;Dec2014, Vol. 22 Issue 12, p24 

    The article presents answers and question related to management and treatment of pediatric stroke including the type of neuroimaging required for the same, appropriate pediatric dose of tissue plasminogen activator (t-PA) and the role of neurointervention.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics